Cargando…
Investigation of Metal-Organic Framework-5 (MOF-5) as an Antitumor Drug Oridonin Sustained Release Carrier
Oridonin (ORI) is a natural active ingredient with strong anticancer activity. But its clinical use is restricted due to its poor water solubility, short half-life, and low bioavailability. The aim of this study is to utilize the metal organic framework material MOF-5 to load ORI in order to improve...
Autores principales: | Chen, Gongsen, Luo, Juyuan, Cai, Mengru, Qin, Liuying, Wang, Yibo, Gao, Lili, Huang, Pingqing, Yu, Yingchao, Ding, Yangming, Dong, Xiaoxv, Yin, Xingbin, Ni, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767262/ https://www.ncbi.nlm.nih.gov/pubmed/31527488 http://dx.doi.org/10.3390/molecules24183369 |
Ejemplares similares
-
Metal Organic Frameworks as Drug Targeting Delivery Vehicles in the Treatment of Cancer
por: Cai, Mengru, et al.
Publicado: (2020) -
Functionalization of MOF-5 with mono-substituents: effects on drug delivery behavior
por: Cai, Mengru, et al.
Publicado: (2020) -
In Vitro Toxicity Study of a Porous Iron(III) Metal‒Organic Framework
por: Chen, Gongsen, et al.
Publicado: (2019) -
Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers
por: Leng, Xin, et al.
Publicado: (2018) -
Oridonin enhances antitumor effects of doxorubicin in human osteosarcoma cells
por: Kazantseva, Liliya, et al.
Publicado: (2021)